Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years
Conditions
Interventions
S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
Placebo
Locations
9
China
Hezhou Center for Disease Control and Prevention
Hezhou, Guangxi, China
Luzhai Center for Disease Control and Prevention
Luzhai, Guangxi, China
Sanjiang Center for Disease Control and Prevention
Sanjiang, Guangxi, China
Zhongshan Center for Disease Control and Prevention
Zhongshan, Guangxi, China
Yongnian Center for Disease Control and Prevention
Handan, Hebei, China
Yuanshi Center for Disease Control and Prevention
Huaiyang, Hebei, China
Start Date
December 11, 2021
Primary Completion Date
January 11, 2024
Completion Date
January 11, 2024
Last Updated
January 11, 2022
NCT05959616
NCT05182749
NCT02736968
NCT03527173
NCT03491228
NCT03561181
Lead Sponsor
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions